(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

THERAPURE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

THERAPURE

ST13

US500000076503605

Class

35

Filing

76503605

Registration

2819327

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

21

Latest update

02/10/2025

Trademark type

Word

Nice classes

35

Filing date

04/03/2003

Registration date

03/02/2004

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/04/2024

Last transaction

02/10/2025

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

1999-00-00

First use in commerce

1999-00-00

Drawing code

1

Owner type

01

Owner location

MENIFEE, CA

Examiner

AXILBUND, MELVIN

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Tollefson, Jeff
Tollefson, Jeff

Representatives

Maria v. Hardison TASSAN & HARDISON

Technical classification

Nice Classes

Class 35

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

DISTRIBUTORSHIP SERVICES IN THE FIELD OF HEALTH PRODUCTSWHOLE FOODSESSENTIAL OILSSANDALSHERBAL PRODUCTS

Publications

History of USPTO decisions and trademark events.

21 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

06/04/2024

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

06/04/2024

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

06/04/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/04/2024

E89R

TEAS SECTION 8 & 9 RECEIVED

02/28/2024

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

03/02/2023

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

03/08/2014

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

03/08/2014

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

03/08/2014

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/08/2014

89AF

REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED

02/18/2014

MAIL

PAPER RECEIVED

02/18/2014

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

06/30/2010

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

05/04/2010

815F

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

03/03/2010

MAIL

PAPER RECEIVED

03/03/2010

R.PR

REGISTERED-PRINCIPAL REGISTER

03/02/2004

PUBO

PUBLISHED FOR OPPOSITION

12/09/2003

NPUB

NOTICE OF PUBLICATION

11/19/2003

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/29/2003

DOCK

ASSIGNED TO EXAMINER

09/28/2003

Continuous trademark protection

Get notified about every new filing that threatens THERAPURE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.